Mold Illness and CIRS in NYC: An Integrative Medicine Approach

New York City's aging building stock, high density, and persistent humidity create conditions where mold exposure is far more common than many physicians — or patients — recognize. For the majority of individuals, exposure to common indoor molds produces limited symptoms that resolve with avoidance. But for a genetically susceptible subset — estimated at 24–28% of the population — mold exposure triggers a condition known as Chronic Inflammatory Response Syndrome (CIRS), a complex, multi-system inflammatory illness that can persist and progress long after the source exposure has ended.

CIRS was systematized by Dr. Ritchie Shoemaker, whose Biotoxin Pathway model describes how certain individuals lack the immunogenetic machinery to clear biotoxins (including mycotoxins from mold), leading to persistent innate immune activation, hypothalamic dysfunction, and widespread systemic effects.

At Regen Health Physicians NYC, Dr. Ajit Dhaliwal applies integrative medicine principles to CIRS evaluation and management — with particular attention to the genetic, metabolic, and regulatory biology that drives this condition.

Understanding the Biotoxin Pathway

In genetically susceptible individuals (certain HLA-DR haplotypes associated with poor biotoxin clearance), mold mycotoxins are not efficiently tagged for elimination. Instead, they recirculate, continuously stimulating the innate immune system.

Key mechanisms:

• Chronic innate immune activation: Elevated C4a, TGF-β1, MMP-9, and dysregulated cytokine networks
• Hypothalamic-pituitary-adrenal (HPA) disruption: Reduced MSH (melanocyte-stimulating hormone), low ADH (antidiuretic hormone/vasopressin), and dysregulated ACTH — contributing to fatigue, thirst abnormalities, and hormonal disruption
• VEGF suppression: Impaired vascular endothelial growth factor reduces capillary density in muscle and other tissues, driving fatigue and pain
• Neuroinflammation: Activated microglia and neurological TGF-β dysregulation explain the cognitive and psychological symptoms common in CIRS
• Leptin resistance: Elevated leptin with downstream effects on appetite, immune regulation, and cognition

The result is a patient who appears broadly unwell — with fatigue, cognitive dysfunction ("brain fog"), joint pain, headaches, sleep disturbance, and mood changes — but whose standard workup returns largely within normal limits.

The CIRS Patient in NYC

NYC patients with CIRS often present to RHPNY after years of partial diagnoses: chronic fatigue syndrome, fibromyalgia, depression, generalized anxiety, ADHD, and post-Lyme syndrome are common prior labels. The common thread is a multi-system presentation that has never been fully unified.

Clues that raise clinical suspicion for CIRS include:

• Symptoms that intensified during or after living or working in a water-damaged building
• Symptoms improved away from home and worsened on return
• Visible mold in a current or prior home or workplace
• Presence of multiple atypical symptoms across different organ systems
• HLA-DR typing revealing a susceptible immune genotype

RHPNY's Diagnostic Approach

Genetic Testing

HLA-DR/DQ testing identifies whether the patient carries a susceptibility haplotype for poor biotoxin clearance. This is not a diagnosis of CIRS but establishes biological plausibility.

Inflammatory Biomarkers

• C4a: Often markedly elevated in CIRS (>2,830 ng/mL)
• TGF-β1: Elevated in CIRS, correlating with fibrotic and immune dysregulation
• MSH: Frequently low in CIRS; mediates circadian rhythm, immune regulation, and pain modulation
• MMP-9: Matrix metalloproteinase elevated in biotoxin illness
• ADH and Osmolality: Dysregulation explains thirst dysregulation and frequent urination

Visual Contrast Sensitivity (VCS) Testing

This validated, inexpensive test assesses a specific neurological deficit — contrast sensitivity — that is reliably impaired in biotoxin illness. Dr. Shoemaker's validation data supports VCS as a practical screening tool. Abnormal VCS in a symptomatic patient with environmental history is a meaningful indicator.

Neuroimaging and Cognitive Assessment

When neurological symptoms dominate, neuroimaging (particularly NeuroQuant MRI if available) and cognitive testing provide objective evidence of central nervous system involvement.

The Shoemaker Protocol and RHPNY's Adaptation

The Shoemaker Protocol is a structured, 11-step treatment sequence. Dr. Dhaliwal adapts this framework to individual patients, emphasizing:

Step 1: Remove from Exposure No treatment succeeds while the patient remains in the source environment. Building inspection (ERMI testing), remediation assessment, and patient relocation guidance are foundational.

Step 2: Cholestyramine or Welchol (Biotoxin Binders) These bile acid sequestrants bind mycotoxins in the gut, interrupting enterohepatic recirculation. Timing, dosing, and medication interactions require physician management.

Step 3: Treating MARCONS Many CIRS patients harbor Multi-Antibiotic Resistant Coagulase Negative Staphylococci (MARCONS) in the nasal sinuses, maintaining a continuous inflammatory trigger. Treatment with intranasal BEG spray or alternative antimicrobials is part of the protocol.

Step 4–11: Correcting Downstream Deficits Subsequent steps address VIP (vasoactive intestinal peptide) supplementation, hormonal normalization (MSH, ADH, cortisol), VEGF correction, metabolic optimization, and — for some patients — low-dose immunotherapy.

Integrative Additions at RHPNY

Dr. Dhaliwal adds complementary strategies including:

• Peptide therapy for inflammatory modulation and tissue repair (VIP, KPV, BPC-157)
• Hormone optimization to address HPA axis dysregulation secondary to CIRS
• Mitochondrial support for the energy deficit central to the CIRS phenotype

A Complex Problem Deserves a Systematic Approach

CIRS is not a simple condition with a simple fix. The patients who do best are those who engage with a structured protocol, make environmental changes consistently, and maintain physician oversight through the treatment sequence. NYC presents unique challenges: aging residential stock, reluctant landlords, and real estate pressures that make relocation difficult. Dr. Dhaliwal works with patients to navigate these realities practically.

Book a consultation with RHPNY if you suspect mold illness or CIRS may be driving your symptoms. Our chronic disease management program provides the integrative foundation this complex condition requires. For patients with concurrent cognitive or neurological symptoms, our regenerative medicine services offer additional support.

Medical Disclaimer

CIRS is a clinically and scientifically complex condition. The diagnostic and treatment framework described is based on the Shoemaker Protocol and integrative clinical experience; it is not yet universally accepted within mainstream medicine. This article is for educational purposes only. Diagnosis and treatment of CIRS require physician evaluation and individualized care.